HAYAT PHARMACEUTICAL INDUSTRIES CO.

To: Jordan Securities Commission,

ﺔﻴﻟﺎﻤﻟﺍ ﻕﺍﺭﻭﻻﺍ ﺔﺌﻴﻫ ﺓﺩﺎﺴﻟﺍ

Amman Stock Exchange

ﻥﺎﻤﻋ ﺔﺻﺭﻮﺑ ﺓﺩﺎﺴﻟﺍ

Company's Name: HAYAT PHARMACEUTICAL

ﺔﻴﺋﺍﻭﺪﻟﺍ ﺕﺎﻋﺎﻨﺼﻠﻟ ﺓﺎﻴﺤﻟﺍ :ﺔﻛﺮﺸﻟﺍ ﻢﺳﺍ

INDUSTRIES CO.

AM 09:20:08 2024-04-04 :ﺦﻳﺭﺎﺘﻟﺍ

Date: 04-04-2024 09:20:08 AM

ﻱﺩﺎﻌﻟﺍ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﻉﺎﻤﺘﺟﺍ ﺭﻮﻀﺤﻟ ﺓﻮﻋﺩ :ﻉﻮﺿﻮﻤﻟﺍ

Subject: Invitation to Attend the Ordinary General

Assembly Meeting

The Board of Directors of HAYAT PHARMACEUTICAL

ﺭﻮﻀﺤﻟ ﻢﻜﺗﻮﻋﺩ ﺔﻴﺋﺍﻭﺪﻟﺍ ﺕﺎﻋﺎﻨﺼﻠﻟ ﺓﺎﻴﺤﻟﺍ ﺓﺭﺍﺩﺍ ﺲﻠﺠﻣ ﺮﺴﻳ

INDUSTRIES CO. cordially invites you to attend the

-25 ﺦﻳﺭﺎﺘﺑ ﻩﺪﻘﻋ ﻱﻮﻨﻤﻟﺍ ﺔﻛﺮﺸﻠﻟ ﻱﺩﺎﻌﻟﺍ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﻉﺎﻤﺘﺟﺍ

company's Ordinary General Assembly Meeting which

ﻲﺋﺮﻤﻟﺍ ﻲﻧﻭﺮﺘﻜﻟﻻﺍ ﻝﺎﺼﺗﻻﺍ ﺔﻠﻴﺳﻭ ﻲﻓ 11:00 ﺔﻋﺎﺴﻟﺍ 2024-04

will be held at 11:00 on 25-04-2024 at By Means of

:ﻲﻟﺎﺘﻟﺍ ﻝﺎﻤﻋﻻﺍ ﻝﻭﺪﺟ ﺔﺸﻗﺎﻨﻤﻟ ﻚﻟﺫﻭ (ZOOM) ﻉﻮﻤﺴﻤﻟﺍﻭ

electronic communication to discuss the following

matters:

Subject:

:ﻉﻮﺿﻮﻤﻟﺍ

Reciting and approving the minutes of the previous

ﺪﻘﻌﻨﻤﻟﺍﻭ ﻖﺑﺎﺴﻟﺍ ﻱﺩﺎﻌﻟﺍ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﻉﺎﻤﺘﺟﺍ ﺮﻀﺤﻣ ﺓﺀﺍﺮﻗ

ordinary meeting of the General Assembly which was

ﻪﻴﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍﻭ 2023-04-12 ﺦﻳﺭﺎﺘﺑ

held on 12-04-2023

The Report of the Board of Directors on the activities of

ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻛﺮﺸﻟﺍ ﻝﺎﻤﻋﺍ ﻦﻋ ﺓﺭﺍﺩﻻﺍ ﺲﻠﺠﻣ ﺮﻳﺮﻘﺗ

the Company during the year 31-12-2023 along with its

ﺔﻛﺮﺸﻠﻟ ﺔﻴﻠﺒﻘﺘﺴﻤﻟﺍ ﺔﻄﺨﻟﺍﻭ 2023-12-31 ﻲﻓ

future plans

The Report of the Company's auditors on its financial

ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻴﻟﺎﻤﻟﺍ ﺕﺎﻧﺎﻴﺒﻟﺍ ﻝﻮﺣ ﺕﺎﺑﺎﺴﺤﻟﺍ ﻲﻘﻗﺪﻣ ﺮﻳﺮﻘﺗ

statements for the year ended 31-12-2023

2023-12-31 ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ

The financial statements for the year ended 31-12-2023

2023-12-31 ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻴﻟﺎﻤﻟﺍ ﺕﺎﻧﺎﻴﺒﻟﺍ

Specifying the profits that the Board of Directors proposes

ﻊﻳﺯﻮﺘﻠﻟ ﺓﺭﺍﺩﻹﺍ ﺲﻠﺠﻣ ﺎﻬﺣﺮﺘﻘﻳ ﻲﺘﻟﺍ ﺡﺎﺑﺭﻷﺍ ﺪﻳﺪﺤﺗ

to distribute

ﻪﺘﺒﺴﻧ ﺎﻣ ﻊﻳﺯﻮﺘﺑ ﺔﻛﺮﺸﻟﺍ ﺓﺭﺍﺩﺍ ﺲﻠﺠﻣ ﺔﻴﺻﻮﺗ ﻰﻠﻋ ﺖﻳﻮﺼﺘﻟﺍ

Approving the recommendation of the company's board

ﻡﺎﻌﻟﺍ ﻦﻋ ﻦﻴﻤﻫﺎﺴﻤﻟﺍ ﻰﻠﻋ ﺡﺎﺑﺭﺄﻛ ﻝﺎﻤﻟﺍ ﺱﺃﺭ ﻦﻣ %16.50

of directors to distribute 16.50% of the capital as

ﺕﺎﺼﺼﺨﻤﻟﺍﻭ ﺕﺎﻃﺎﻴﺘﺣﻻﺍﻭ ،2023

dividends to shareholders for the year 2023, reserves and

.provisions

Discharging the Board's members from their liabilities in

ﻢﻬﺗﺎﻓﺮﺼﺗ ﻦﻋ ﺔﻴﻟﻭﺆﺴﻤﻟﺍ ﻦﻣ ﺓﺭﺍﺩﻻﺍ ﺲﻠﺠﻣ ﺀﺎﻀﻋﺃ ﺔﻣﺫ ﺀﺍﺮﺑﺍ

respect of the financial year ended 31-12-2023

2023-12-31 ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻨﺴﻟﺍ ﻝﻼﺧ

Electing the Company's auditors for the next fiscal year,

ﺪﻳﺪﺤﺗﻭ ﺔﻠﺒﻘﻤﻟﺍ ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻛﺮﺸﻟﺍ ﺕﺎﺑﺎﺴﺣ ﻲﻘﻗﺪﻣ ﺏﺎﺨﺘﻧﺍ

and deciding on their remunerations or authorizing the

ﺎﻫﺪﻳﺪﺤﺘﺑ ﺓﺭﺍﺩﻹﺍ ﺲﻠﺠﻣ ﺾﻳﻮﻔﺗ ﻭﺍ ﻢﻬﺑﺎﻌﺗﺃ

Board of Directors to determine such remunerations

Page 1 of 2

HAYAT PHARMACEUTICAL INDUSTRIES CO.

Please accept our sincere thanks and appreciation. Chairman of Board of Directors

User Name: Yasmeen Al-shibi

.ﻡﺍﺮﺘﺣﻻﺍ ﻖﺋﺎﻓ ﻝﻮﺒﻘﺑ ﺍﻮﻠﻀﻔﺗﻭ ﺓﺭﺍﺩﻹﺍ ﺲﻠﺠﻣ ﺲﻴﺋﺭ Yasmeen Al-shibi :ﻡﺪﺨﺘﺴﻤﻟﺍ ﻢﺳﺍ

Page 2 of 2

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Hayat Pharmaceutical Industries Co. PSC published this content on 04 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 April 2024 07:05:04 UTC.